It’s been one year since Seegene produced a complete respiratory diagnostic test that has taken the uncertainty out of differentiating COVID-19 infection from other respiratory illnesses Fast Response In January 2020, before a single patient with SARS-CoV-2 virus had been…
High Multiplex assays that test for many common pathogens at once can accelerate diagnostics and facilitate a higher quality of care When a patient presents with a symptom, many pathogens could be at fault. Standard clinical practice is to take…
Seegene's competitors' PCR tests identify only one COVID-19 variant at a time, and so fall short as a solution to current requirements, given today’s massive testing demands and the need to identify multiple COVID-19 variants as quickly as possible. Seegene’s…
A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine, led by…
Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases. The new CE-IVD marked variants detection kit to differentiate 10 major COVID-19…
Seegene announces partnership with Bio-Rad for the development and commercialization of infectious disease molecular diagnostic products Diagnostic tests designed for the pandemic and the post-pandemic era with high multiplex technology A significant step forward for Seegene in expanding its business…
Seegene unveils "MOBILE STATION" at the Medlab Middle East 2021 Mobile laboratory designed for mass testing at schools, airports, or communities, delivering test results within 3h 30min with the maximum testing capacity of 7,500 a day The biotechnology firm to…